Published on 29 Mar 2024 on Zacks via Yahoo Finance
Have you been paying attention to shares of Artivion (AORT)? Shares have been on the move with the stock up 9.6% over the past month. The stock hit a new 52-week high of $21.82 in the previous session. Artivion has gained 18.3% since the start of the year compared to the 8.2% move for the Zacks Medical sector and the 9.4% return for the Zacks Medical - Instruments industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on February 15, 2024, Artivion reported EPS of $0.11 versus consensus estimate of $-0.13 while it beat the consensus revenue estimate by 4.37%.